Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.
about
Review and uses of stereotactic body radiation therapy for oligometastasesStereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerComplications from Stereotactic Body Radiotherapy for Lung CancerDosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastasesCritical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapyClinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancerCorrelation between tumor size and blood volume in lung tumors: a prospective study on dual-energy gemstone spectral CT imaging.Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis.Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy.Organizing pneumonia after stereotactic ablative radiotherapy of the lung.Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion.The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changesStereotactic ablative radiotherapy in the UK: current status and developmentsThe impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung.VERO® radiotherapy for low burden cancer: 789 patients with 957 lesionsSimilar-case-based optimization of beam arrangements in stereotactic body radiotherapy for assisting treatment planners.Stereotactic body radiotherapy for early stage lung cancer.Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team.Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy.The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastaSurgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?The development of stereotactic body radiotherapy in the past decade: a global perspective.Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms.Computer-aided beam arrangement based on similar cases in radiation treatment-planning databases for stereotactic lung radiation therapy.Lobectomy: no port at all?Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT
P2860
Q26864247-1CC3B65E-0B92-4CD3-88FA-7E7193361007Q26866335-46E0960C-BB94-4F20-8B46-F91F921C0A4CQ26995851-9D197A27-09F0-4D63-A519-7FC6F2ED1506Q28730322-36EDEBB4-AD0F-4B77-B2A3-91C08B348B80Q28950857-33689E25-CDA3-467B-B3CB-0F2A1B5E0520Q30570350-82A33109-AFD8-44DB-A341-C0ED196F061EQ33813917-83A159D8-9530-4BE0-89A6-BFF68B438F6DQ34366518-88E02001-1E78-4FAF-A94F-DBD3E1B88B48Q35663626-2FCE4E7C-3E8E-4280-9543-67706C7DA64FQ36042363-80BECC33-E4A3-4B46-AD1D-57052D4CB173Q36346363-CEE6369D-E085-4AA5-9A78-8933D7DAB971Q36499983-FFCAC11F-C042-4475-BA25-0E9CFD068A32Q36642258-FFA49BA0-8533-471C-AE9C-345FD0C32B53Q37127178-DD3086F8-7FBD-413F-813C-3568A18EE032Q37301100-8E501E72-43D3-4D80-8074-E1A106890A85Q37301542-4D3B8736-42E2-4AE0-B328-2DB079D38FF9Q37330495-89AFF50D-8AAB-4045-BA67-F63540DE69AFQ38155155-5106AD7F-54B3-446A-BBA7-749E36FCED8CQ38161371-D2633B8B-495B-4A96-B65D-06DD2BB4D0ADQ38178429-BFE5CB9D-8187-402B-8B6E-6C49381B7EBEQ38227883-6F83284E-8456-4916-8DDC-4CA6C81E16CAQ38367507-5E86F5C7-73C0-462B-84D9-2964027BD27AQ38967475-71A68980-1F6C-4F28-BA1B-CB0ECE495582Q39186802-3C06E2ED-58D1-4F89-BDF8-F9E090278797Q40370986-1330944A-B2F5-4743-83C3-5D70E12AF150Q40611044-E98F8769-1392-4EF1-808A-8BDFE49597A7Q42348006-94739DD8-436D-4E7B-969A-CFD3882334EFQ54968888-3E83206F-8F3C-4D1F-9D0F-7D394109E575
P2860
Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@en
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@nl
type
label
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@en
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@nl
prefLabel
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@en
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@nl
P2093
P1476
Stereotactic radiotherapy of p ...... national Atomic Energy Agency.
@en
P2093
Branislav Jeremic
Frank Zimmermann
Ingmar Lax
Joern Wulf
Robert Timmerman
Yasushi Nagata
P304
P356
10.1016/J.IJROBP.2010.10.004
P407
P577
2011-03-01T00:00:00Z